Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten B Meissner

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Microbes and Infection|January 3, 2012
NLRC5: a newly discovered MHC class I transactivator (CITA)Torsten B Meissner, Amy Li, Koichi S Kobayashi
Current Stem Cell Reports|November 21, 2022
Immune Editing: Overcoming Immune Barriers in Stem Cell TransplantationTorsten B Meissner, Henrike S Schulze, Stanley M Dale
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2012
Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivatorAmlan Biswas, Torsten B Meissner, Taro Kawai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 7, 2015
Genome-Edited Human Pluripotent Stem Cell-Derived Macrophages as a Model of Reverse Cholesterol Transport--Brief ReportRajat M Gupta, Torsten B Meissner, Chad A Cowan, et al.
Trends in Immunology|March 11, 2017
HLA-G: At the Interface of Maternal-Fetal ToleranceLeonardo M R Ferreira, Torsten B Meissner, Tamara Tilburgs, et al.
Frontiers in Immunology|January 11, 2020
The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal InterfaceHenrieta Papúchová, Torsten B Meissner, Qin Li, et al.
Biochemical and Biophysical Research Communications|February 8, 2012
The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activityTorsten B Meissner, Amy Li, Yuen-Joyce Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2024
HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axisBowen Gu, Gia-Han Le, Sebastian Herrera, et al.
Methods in Enzymology|November 16, 2014
Genome editing for human gene therapyTorsten B Meissner, Pankaj K Mandal, Leonardo M R Ferreira, et al.
Frontiers in Immunology|August 19, 2021
Fast and Efficient Genome Editing of Human FOXP3<sup>+</sup> Regulatory T CellsLauren Van Zeebroeck, Rebeca Arroyo Hornero, Beatriz F Côrte-Real, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Microbes and Infection|January 3, 2012
NLRC5: a newly discovered MHC class I transactivator (CITA)Torsten B Meissner, Amy Li, Koichi S Kobayashi
Current Stem Cell Reports|November 21, 2022
Immune Editing: Overcoming Immune Barriers in Stem Cell TransplantationTorsten B Meissner, Henrike S Schulze, Stanley M Dale
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2012
Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivatorAmlan Biswas, Torsten B Meissner, Taro Kawai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 7, 2015
Genome-Edited Human Pluripotent Stem Cell-Derived Macrophages as a Model of Reverse Cholesterol Transport--Brief ReportRajat M Gupta, Torsten B Meissner, Chad A Cowan, et al.
Trends in Immunology|March 11, 2017
HLA-G: At the Interface of Maternal-Fetal ToleranceLeonardo M R Ferreira, Torsten B Meissner, Tamara Tilburgs, et al.
Frontiers in Immunology|January 11, 2020
The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal InterfaceHenrieta Papúchová, Torsten B Meissner, Qin Li, et al.
Biochemical and Biophysical Research Communications|February 8, 2012
The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activityTorsten B Meissner, Amy Li, Yuen-Joyce Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2024
HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axisBowen Gu, Gia-Han Le, Sebastian Herrera, et al.
Methods in Enzymology|November 16, 2014
Genome editing for human gene therapyTorsten B Meissner, Pankaj K Mandal, Leonardo M R Ferreira, et al.
Frontiers in Immunology|August 19, 2021
Fast and Efficient Genome Editing of Human FOXP3<sup>+</sup> Regulatory T CellsLauren Van Zeebroeck, Rebeca Arroyo Hornero, Beatriz F Côrte-Real, et al.
Pageof 3